What are the essential steps in managing hemolytic disease of the fetus and newborn (HDFN)? How soon after “the cord has been cut” does newborn care transfer from the maternal-fetal medicine specialist and ob-gyn to the pediatric team? This satellite symposium will help you better understand how care for neonates with hemolytic disease has evolved and provide you with the latest recommendations for timely evaluation and treatment—plus insights on how these might change the way you practice!
Pathophysiology from the MFM Perspective: Underlying Alloimmune Disorders of the Fetus/Newborn, Including HDFN and HDN Management
Kara B. Markham, MD
7:25 pm–7:35 pm
The Role of the Neonatal Fc Receptor Pathway as a Therapeutic Means to Address HDFN and Other Fetal/Neonatal Alloimmune Disorders
Kara B. Markham, MD
7:35 pm–7:55 pm
Pathophysiology from the Pediatric Perspective: Marrow Suppression, NICU Management
James B. Bussel, MD
7:55 pm–8:10 pm
Patient Perspective: The Psychological and Social Impact of Maternal Alloimmunization and HDFN on Women Experiencing These Disorders and Their Families (Advocacy/Allo Hope Foundation’s Resources)
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty: Kara B. Markham, MD Associate Professor of Clinical Obstetrics & Gynecology University of Cincinnati Cincinnati, OH
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1.5 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.
Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited Reproduction of this material is not permitted without written permission from the copyright owner.
This symposium is not sponsored, endorsed or accredited by the American Academy of Pediatrics.
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Kate Nagele prior to the live event at knagele@glc.healthcare.
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.
What are the essential steps in managing hemolytic disease of the fetus and newborn (HDFN)? How soon after “the cord has been cut” does newborn care transfer from the maternal-fetal medicine specialist and ob-gyn to the pediatric team? This satellite symposium will help you better understand how care for neonates with hemolytic disease has evolved and provide you with the latest recommendations for timely evaluation and treatment—plus insights on how these might change the way you practice!
Pathophysiology from the MFM Perspective: Underlying Alloimmune Disorders of the Fetus/Newborn, Including HDFN and HDN Management
Kara B. Markham, MD
7:25 pm–7:35 pm
The Role of the Neonatal Fc Receptor Pathway as a Therapeutic Means to Address HDFN and Other Fetal/Neonatal Alloimmune Disorders
Kara B. Markham, MD
7:35 pm–7:55 pm
Pathophysiology from the Pediatric Perspective: Marrow Suppression, NICU Management
James B. Bussel, MD
7:55 pm–8:10 pm
Patient Perspective: The Psychological and Social Impact of Maternal Alloimmunization and HDFN on Women Experiencing These Disorders and Their Families (Advocacy/Allo Hope Foundation’s Resources)
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Faculty: Kara B. Markham, MD Associate Professor of Clinical Obstetrics & Gynecology University of Cincinnati Cincinnati, OH
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this activity for 1.5 nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should claim only the credit commensurate with the extent of their participation in the activity.
Prova Education designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties.
Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited Reproduction of this material is not permitted without written permission from the copyright owner.
This symposium is not sponsored, endorsed or accredited by the American Academy of Pediatrics.
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Kate Nagele prior to the live event at knagele@glc.healthcare.
Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.
Facebook Comments